<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03234647</url>
  </required_header>
  <id_info>
    <org_study_id>Doraya FIH Study for AHF</org_study_id>
    <nct_id>NCT03234647</nct_id>
  </id_info>
  <brief_title>First In Human Study of the Doraya Catheter for the Treatment of AHF Patients</brief_title>
  <official_title>First In Human Study of the Doraya Catheter for the Treatment of AHF Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Revamp Medical Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Revamp Medical Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Safety and performance evaluation of the Doraya catheter in patients admitted with AHF.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this clinical investigation is to evaluate the safety and performance of the
      Doraya catheter in patients admitted with AHF, presenting persistent volume over load and
      poor response to diuretic treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Device or procedure related Serious Adverse Event (SAE) rate through 60 days</measure>
    <time_frame>60 days</time_frame>
    <description>SAE as defined by ISO 14155</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Acute Heart Failure</condition>
  <arm_group>
    <arm_group_label>AHF patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AHF patient treatment with the Doraya catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Doraya catheter</intervention_name>
    <description>Temporary deployment of the Doraya catheter in AHF patients.</description>
    <arm_group_label>AHF patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AHF subjects with poor diuretic response

        Exclusion Criteria:

          -  AHF subjects with sufficient diuretic response
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tal Hasin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shaare Zedek Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simona Beilin-Nissan</last_name>
    <phone>+972-54-6603119</phone>
    <email>SimonaB@revampmedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lihu Avitov</last_name>
    <phone>+972-52-467-9991</phone>
    <email>LihuA@revampmedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Onze-Lieve-Vrouwziekenhuis Aalst</name>
      <address>
        <city>Aalst</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy De Knijf</last_name>
      <email>Kathy.De.Knijf@olvz-aalst.be</email>
    </contact>
    <investigator>
      <last_name>Riet Dierickx</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ZNA Middelheim</name>
      <address>
        <city>Antwerpen</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Inge Joris</last_name>
      <email>Inge.Joris@zna.be</email>
    </contact>
    <investigator>
      <last_name>Stefan Verheye</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>July 19, 2017</study_first_submitted>
  <study_first_submitted_qc>July 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2017</study_first_posted>
  <last_update_submitted>September 25, 2018</last_update_submitted>
  <last_update_submitted_qc>September 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

